Literature DB >> 23716715

Adenosine promotes tumor metastasis.

Joel Linden1.   

Abstract

An early step in tumor metastasis is a reduction in cell-cell adhesion to enable cell scattering. Contacts between cells are stabilized by accumulation in the plasma membrane of the small guanosine triphosphatase (GTPase) Rap1B. The membrane localization of Rap1B is increased when it is posttranslationally modified by prenylation of its C-terminal Cys-Ala-Ala-X motif. A new study shows that Rap1B prenylation and plasma membrane localization were reduced when Rap1B was phosphorylated by protein kinase A (PKA). In some tumors, high adenosine production and an abundance of G(s)-coupled adenosine A(2B) receptors would be expected to cause persistent PKA signaling and reduced Rap1B prenylation. These findings suggest that adenosine signaling reduces prenylation and plasma membrane localization of Rap1B, resulting in enhanced tumor cell scattering and invasiveness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716715     DOI: 10.1126/scisignal.2004290

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  4 in total

1.  β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.

Authors:  Jessica M Wilson; Ellen Lorimer; Michael D Tyburski; Carol L Williams
Journal:  Cancer Biol Ther       Date:  2015-07-24       Impact factor: 4.742

Review 2.  Pathological overproduction: the bad side of adenosine.

Authors:  Pier Andrea Borea; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Katia Varani
Journal:  Br J Pharmacol       Date:  2017-03-31       Impact factor: 8.739

3.  Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Vidula Sukhatme; Lydie Meheus; Ilse Rooman; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-10-12

4.  A new signaling paradigm to control the prenylation and trafficking of small GTPases.

Authors:  Carol L Williams
Journal:  Cell Cycle       Date:  2013-08-23       Impact factor: 4.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.